218 related articles for article (PubMed ID: 11063900)
1. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study.
Mosekilde L; Beck-Nielsen H; Sørensen OH; Nielsen SP; Charles P; Vestergaard P; Hermann AP; Gram J; Hansen TB; Abrahamsen B; Ebbesen EN; Stilgren L; Jensen LB; Brot C; Hansen B; Tofteng CL; Eiken P; Kolthoff N
Maturitas; 2000 Oct; 36(3):181-93. PubMed ID: 11063900
[TBL] [Abstract][Full Text] [Related]
2. [Hormone replacement therapy reduces the risk of forearm fracture in postmenopausal women. Results of the Danish Osteoporosis Prevention Study].
Mosekilde L; Beck-Nielsen H; Sørensen OH; Nielsen SP; Charles P; Vestergaard P; Hermann AP; Gram J; Hansen TB; Abrahamsen B; Ebbesen EN; Stilgren LS; Jensen LB; Brot C; Hansen B; Tofteng CL; Eiken PA; Kolthoff NU
Ugeskr Laeger; 2001 Dec; 163(50):7064-9. PubMed ID: 11794040
[TBL] [Abstract][Full Text] [Related]
3. Improving compliance with hormonal replacement therapy in primary osteoporosis prevention.
Vestergaard P; Hermann AP; Gram J; Jensen LB; Kolthoff N; Abrahamsen B; Brot C; Eiken P
Maturitas; 1997 Dec; 28(2):137-45. PubMed ID: 9522321
[TBL] [Abstract][Full Text] [Related]
4. Does hormone-replacement therapy prevent fractures in early postmenopausal women?
Randell KM; Honkanen RJ; Kröger H; Saarikoski S
J Bone Miner Res; 2002 Mar; 17(3):528-33. PubMed ID: 11874244
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk for foot, distal forearm, proximal humerus, and pelvis fractures.
Keegan TH; Gopalakrishnan G; Sidney S; Quesenberry CP; Kelsey JL
Osteoporos Int; 2003 Jul; 14(6):469-75. PubMed ID: 12761609
[TBL] [Abstract][Full Text] [Related]
6. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women.
Mosekilde L; Hermann AP; Beck-Nielsen H; Charles P; Nielsen SP; Sørensen OH
Maturitas; 1999 Mar; 31(3):207-19. PubMed ID: 10340280
[TBL] [Abstract][Full Text] [Related]
7. Fracture reducing potential of hormone replacement therapy on a population level.
Vestergaard P; Rejnmark L; Mosekilde L
Maturitas; 2006 Jun; 54(3):285-93. PubMed ID: 16413706
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
[TBL] [Abstract][Full Text] [Related]
9. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
Komulainen MH; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Saarikoski S
Maturitas; 1998 Nov; 31(1):45-54. PubMed ID: 10091204
[TBL] [Abstract][Full Text] [Related]
10. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
[TBL] [Abstract][Full Text] [Related]
11. Increased reduction in bone density and skin thickness in postmenopausal women on long-term corticosteroid therapy. A suggested role for estrogen add back therapy.
Baron YM; Brincat M; Galea R
Adv Exp Med Biol; 1999; 455():429-36. PubMed ID: 10599380
[TBL] [Abstract][Full Text] [Related]
12. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
13. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
14. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
[TBL] [Abstract][Full Text] [Related]
16. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.
Weiss NS; Ure CL; Ballard JH; Williams AR; Daling JR
N Engl J Med; 1980 Nov; 303(21):1195-8. PubMed ID: 7421945
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis intervention following distal forearm fractures: a missed opportunity?
Cuddihy MT; Gabriel SE; Crowson CS; Atkinson EJ; Tabini C; O'Fallon WM; Melton LJ
Arch Intern Med; 2002 Feb; 162(4):421-6. PubMed ID: 11863474
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
19. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy.
Wu F; Ames R; Clearwater J; Evans MC; Gamble G; Reid IR
Clin Endocrinol (Oxf); 2002 Jun; 56(6):703-11. PubMed ID: 12072039
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for perimenopausal distal forearm fracture.
Honkanen RJ; Honkanen K; Kröger H; Alhava E; Tuppurainen M; Saarikoski S
Osteoporos Int; 2000; 11(3):265-70. PubMed ID: 10824244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
